-
Dalziel, K, Round, A, Garside, R, Stein, K.
Cost effectiveness of imatinib compared with interferon-α or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia.
PharmacoEconomics
23(5)
:
515 -526
2005
view publication
-
Dalziel, K, Round, A, Stein, K, Garside, R, Castelnuovo, E, Payne, L.
Do the findings of case series studies vary significantly according to methodological characteristics?.
Health Technology Assessment
9(2)
:
iii -146
2005
view publication
-
Dalziel, K, Round, A, Stein, K, Garside, R, Price, A.
Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis.
Health Technology Assessment
8(28)
:
iii -120
2004
view publication
-
Stein, K, Dalziel, K, Walker, A, Jenkins, B, Round, A, Royle, P.
Screening for Hepatitis C in injecting drug users: a cost utility analysis.
Journal of Public Health
26(1)
:
61 -71
2004
view publication
-
Smith, BJ, Cheok, F, Heard, AR, Esterman, AJ, Southcott, AM, Antic, R, Frith, PA, Hender, K, Ruffin, RE.
Impact on readmission rates and mortality of a chronic obstructive pulmonary disease inpatient management guideline.
Chronic Respiratory Disease
1(1)
:
17 -28
2004
view publication